BeOne Medicines outlines $5.1B–$5.3B 2025 revenue target amid BRUKINSA momentum and expanding pipeline
Earnings Call Insights: BeOne Medicines AG (ONC) Q3 2025 Management View John Oyler, Co-Founder, Executive Chairman & CEO, described Q3 as a period of "another strong quarter of execution," highlighting that "revenue reached $1.4 billion, which represents...
Seeking Alpha